Putting Australian Cannabis Patients First

Cannabis importers allegedly held to different standards.

Responding to recent media reports regarding imported cannabis products, Biortica Agrimed CEO, Tom Varga commented, “Let’s all just keep in mind what our priority is here. This is about providing the highest quality medicinal cannabis, affordably, to Australian patients in need.”

“There is an Australian shortage of medicinal cannabis. As Australia’s largest B2B medicinal cannabis grower, our goal is full import replacement and ultimately export as well, but let’s get patients the treatment they need first.”

“What I will say however, is that all medicinal cannabis supplied to patients must meet Australian standards of efficacy and safety.”

“All medicinal cannabis needs to comply with TGO 93 and TGO 100 as a minimum. No ifs, buts or exceptions,” he said.

“To patients and practitioners I’d say, look for the ‘Product of Australia’ logo as your guarantee of efficacy and safety.”